(Synercid®), a synthetically modified streptogramin, is presently the sole effective agent in the treatment of some MDRnosocomial infections. A Streptomyces coelicolor transcriptional regulator (Pip) has been adapted to modulate reporter gene expression (SEAP, secreted alkaline phosphatase) in Chinese hamster ovary cells (CHO)in response to streptogramin antibiotics. This CHOcell-based technology was more sensitive in detecting the production of the model streptogramin pristinamycin, from Streptomyces pristinaespiralis, than antibiogram tests using a variety of humanpathogenic bacteria as indicator strains. The reporter system was able to detect pristinamycin compoundproduced by a single S. pristinaespiralis colony. The assay was rapid (17 hours) and could be carried out in a high-throughput 96-well plate assay format or a 24-well transwell set-up. This novel mammaliancell-based antibiotic screening concept enables detection of bioavailable and non-cytotoxic representatives of a particular class of antibiotics in a single assay and represents a promising alternative to traditional antibiogram-based screening programs.
In recent years, there has been a dramatic worldwide increase in the prevalence of MDRhumanpathogenic bacteria resulting in an escalation of bacterial disease and related mortality. the prime antibiotic for successful therapy of the difficultto-treat acute endocarditis15). The low incidence of acquired resistance to streptogramins (a few reported cases in the 50 years of successful streptogramin-based therapy16)) is a result of their composite nature which requires the presence of both a type I-and a type II-specific resistance determinants5'10'17).
Streptogramin-producing Streptomyces such as S. pristinaespiralis, a pristinamycin producer, and S. virginiae, a virginiamycin producer, typically contain resistance determinants to survive the toxic effects of their own antibiotics they produce18^21). In S. pristinaespiralis, production of pristinamycin is thought to induce expression of the pristinamycin resistance gene (ptr)2l\ This is mediated by a repressor (Pip; pristinamycin-induced protein) which binds to dyad symmetrical operator sites overlapping the ptr promoter (Pptr) and prevents ptr expression20 '22 (27) S (30) S (20) S (30) S (28) S (22) R (6) S (26) R (6) S (32) R (6) S (40) S (23) S (30) R (6) S (27) R (6) S (29) S (12) S (19) R (6) S (27) R (9) S (25) R (7) S (21) R (6) R (6) R (6) JAN. 2001 Antibiogram discs containing pristinamycin (15^g), virginiamycin (1 5 Table 2 ). Wetested these strains for their susceptibility to pristinamycin concentrations present in 100jUl of culture supernatant P of S. pristinaespiralis grown in typical antibiotic production medium for 45
hours. 100/il of supernatant is the maximumamount of liquid which can be added to mammalian cultures grown in multi-well plates.
Results of the antibiogram test using a S. pristinaespiralis culture supernatant are shown in Table 2 . Only C. diphtheriae and S. pyogenes were sensitive to the pristinamycin present in 100 /il supernatant disc. However, due to safety concerns, the use of highly human pathogenic C. diphtheriae and S. pyogenes isolates as indicator strains in high-throughput screening programs obviously would Various antibiotics were added to CHO-Scell cultures at a concentration of 2 /ig/ml and SEAPexpression was measured after 48 hours. Only streptogramin antibiotics (pristinamycin (Pyostacin®), virginiamycin, quinupristindalfopristin (Synercid®)) were able to modulate SEAPexpression. In addition, the regulation performance of 100^1 culture supernatants derived from S. pristinaespiralis (see Material and Methods) was assessed using CHO-Scells.
antibiotic may be unstable in aqueous solutions (generally the case for streptogramins). In the configuration presented here, the standard antibiogram test using B. subtilis as indicator bacteria would have failed to detect S. pristinaespiralis as a streptogramin producer.
CHO-S as Screening Platform for the Detection of Streptogramins
CHO-S was constructed to be a highly sensitive streptogramin sensor. Instead of using a physiological readout (inhibition of bacterial growth) as in the antibiogram test, the CHO-S-based detection technology relies on the direct interaction of the antibiotic and the Streptomyces streptogramin sensor Pip which is linked to a transcription readout within a mammalian cell. CHO-Swas able to reliably identify this type of streptogramin in the supernatant as seen by significant reduction in SEAP expression compared to full expression in the absence of any antibiotic (Figure 1) . Based on the correlation between the streptogramin concentration and the SEAP readout of CHO-Sshown in Table 1 , the pristinamycin concentration of the supernatant P was estimated to be between 0.5^g/ml and 1 /Lig/ml.
In preliminary experiments using the CHO-S/CHO-C screening technology as well as C. All antibiotics (2fig/ml) were added to CHOcells harboring the PipON system and SEAPexpression was measured 48 hours post transfection. Also, \00 jill of S. pristinaespiralis culture supernatants were assessed for their SEAP-inducing potential. streptogramin with the Pip molecule will lead to induction of SEAPexpression. Wehave tested the collection of nonstreptogramin antibiotics described above (Figure 1 ) as well as supernatants P, #48 and #49 in CH0-K1cells which have been cotransfected with the Pip-encoding plasmid PMF150
and the PPIRON-driven SEAP expression construct (pMF208). Figure 2 shows the induction profile of these antibiotics and supernatants compared to a response elicited by 2 jug/ml pristinamycin. The streptogramin concentration was assessed 17 hours after transfection using a chemiluminescence-based phosphatase assay. The values indicated are the result of three independent experiments using three different agar plugs and colonies. The one-colony assay was compared to a control set-up using either no antibiotic or 2 /12/ml pristinamvcin.
in supernatant P (between 0.5//g/ml and 1 jug/ml) was comparable to the one determined using CHO-S-based detection technology (PipOFF) as estimated by comparison with the PipON-speciflc streptogramin-SEAP correlation (Table 3) to a high-throughput screening platform able to detect putative streptogramins produced by a single Streptomyces colony grown on agar plates. This most advanced variant of the streptogramin screening technology is based on the PipON system. CH0-K1 cells cotransfected with a Pip expression construct (pMF150) and a Pip-responsive SEAP reporter construct (pMF208; PPIRON-SEAP23))were seeded into 96-well plates. Anagar plug removed from a plate supporting growth of a S. pristinaespiralis colony, grown for 40 hours, was sampled using the tip of a Pasteur pipette (1 mmdiameter). Figure 3A shows the chemiluminesceneebased SEAP readout 17 hours after addition of S. pristinaespiralis colonies or pure pristinamycin. This prototype one-colony set-up proved to be sensitive enough to detect pristinamycin produced by only a single colony; SEAPexpression was significantly induced compared to controls containing Streptomyces-free agar plugs ( Figure   3A ). The one-colony assay only requires handling of liquids and pipetable agar plugs which renders this screening format compatible with commonrobotic high-throughput systems. In addition to the 96-well plate screening format wehave established a transwell high throughput system which involves growing the S. pristinaespiralis colony in an agar-containing transwell chamber. Following 40 hours of incubation, this transwell chamber was placed into a 24 well containing CHO-K1 expressing the PipON system. Pristinamycin production from the S. pristinaespiralis colony diffused through the base of the transwell chamber and induced SEAPexpression which was measured after 17 hours. Comparedto the negative controls (no antibiotic; agar only) the SEAPexpression by the S. pristinaespiralis colony was significantly induced and similar to the PI antibiogram disc ( Figure 3B ). Unlike the 96-well plate format, there is no direct contact between potential streptogramin producers and the screening cells in the transwell set-up which minimizes interference in the screening assay.
Discussion
The incidence of infections caused by multidrug-resistant human pathogens is dramatically increasing. Despite the potential of streptogramins for humantherapy, little attention has been focused on the discovery of novel streptogramin antibiotics in the past decades. The mammaliancell-based screening technology presented here has the potential to detect novel streptogramin activities for application in human therapy. Although the use of the PipONand PipOFF systems is limited to the detection of streptogramin antibiotics, this technology may be applied to screening modalities for other classes of antibiotics using regulatory proteins found in a variety of antibiotic producing organisms or resistant pathogens47^51\ Similar adaptation of these resistance regulons for use as antibiotic detection systems will likely become a powerful tool in drug discovery, to restrain the increasing prevalence of MDRhuman pathogenic bacteria.
THE JOURNAL OF ANTIBIOTICS

